TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT07517445

Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis

Cause of deathSafety Automatic label, confidence 0.9, unverified. How labels are made.
“A temporary precautionary pause in enrolment into all arms of the trial was implemented on 21 July 2026, due to emerging hepatic safety signal. A protocol amendment is currently underway.”

The sponsor’s own words in the registry.

Life of this trial

202620272028Registered2026-04-01Started2026-04-17Suspended (as of)2026-08-10

Vital statistics

Status
Suspended
Phase
Phase 2
Sponsor
Gates Medical Research Institute
Sponsor type
University, hospital or other
Conditions
Drug Susceptible Pulmonary Tuberculosis
Interventions
Bedaquiline, pretomanid, linezolid; Bedaquiline, pretomanid, linezolid; Bedaquiline, pretomanid, linezolid; Nicotinamide (NAM)
Participants
165 (planned, not actual)
Sites
4
Countries
South Africa

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.